Rotations - Medical Oncology-Hematology Fellowship
Medical Oncology Inpatient Consults: Provides fellows with training in the inpatient work-up of patients with known or suspected solid tumor malignancies. Fellows will also see malignancy related complications of established cancer center patients. Consults are staffed with disease-specific attendings which allows for in depth education regarding a variety of solid tumor malignancies.
Blood and Marrow Transplant Inpatient Service: The BMT unit is a 13-bed unit dedicated to patients undergoing either allogeneic or autologous stem cell transplant. Patient composition includes those who are receiving their initial transplant, individuals admitted with transplant complications, or patients requiring repeat transplantation or stem cell boost. The inpatient rounding team is composed of an attending, first year fellow, nurse practitioner, transplant pharmacist, and oncology trained nurses. In addition to daily rounds, there is a weekly meeting of BMT faculty with the fellow to discuss the current inpatients.
Leukemia Inpatient Service: Patient composition include individuals with newly diagnosed or relapsed/refractory acute leukemia, aggressive lymphoma, myelodysplastic syndrome, and chronic leukemia requiring inpatient treatment. Other admissions to the service include individuals admitted with complications of their chemotherapy including febrile neutropenia. Many of these patients are enrolled on a clinical research protocol, which provides the fellow with early exposure to clinical trials. The service is composed of a malignant hematology attending, first year fellow, internal medicine residents, medical students, an oncology pharmacist, pharmacy residents, oncology social worker and case manager, and oncology trained nurses. Fellows also learn and perform bone marrow biopsies, intrathecal, and intraommaya chemotherapy. Fellows rotating on this rotation take a lead role in presenting patients at our weekly leukemia conference in which hematopathology reviews bone marrow biopsies and patient management is discussed.
VA: Infusion/Research: During this rotation, fellows will learn the acute management of various outpatient oncologic complications including chemotherapy infusion reactions, management of chemotherapy side effects, and assessment of a patient for therapy continuation. Fellows will also use this time to perform research in conjunction with faculty members.
Research/Elective: Dedicated time to meet with faculty and initiate a scholarly project. In addition, fellows can use this time to take various electives based on the fellow’s specific interest. Electives include, but are not limited to, hematopathology, transfusion medicine, radiation oncology, gynecologic oncology, palliative care, and external opportunities at the FDA.
Hematology Outpatient: This is a clinic based rotation for the second year fellow. The fellow will rotate through faculty clinics in malignant hematology, lymphoma, multiple myeloma, and benign hematology. The fellow will further their knowledge regarding evidence based management of hematologic conditions as well as learning how to assess a patient for a potential clinical trial. The assigned fellow will participate in both our weekly lymphoma as well as our weekly leukemia case conference.
Thoracic Oncology Outpatient: This is a clinic based rotation for the second year fellow. The fellow will rotate through faculty clinics in both breast and lung cancer. They will take part in multi-disciplinary tumor boards and clinics for both thoracic and breast oncology.
Gastrointestinal Oncology Outpatient: This is a clinic based rotation for the third year fellow. The fellow will rotate through faculty based clinics focusing on head and neck cancer and gastrointestinal malignancies. They will take part in multi-disciplinary tumor boards for GI malignancies.
Genitourinary Oncology Outpatient: This is a clinic based rotation for the third year fellow. The fellow will rotate through faculty based clinics in both breast cancer and genitourinary malignancies. The fellow will take part in tumor boards for both breast and genitourinary malignancies.
University Continuity Clinic: Depending upon the fellow's primary interest in either hematology or oncology, each fellow will be paired with a faculty member and rotate through their continuity clinic for 18 months. This is one of two weekly continuity clinics for the fellow and allows for early exposure to a University based outpatient oncology setting.
VA Continuity Clinics: Fellows are the primary longitudinal oncologic provider for our VA population and see patients in once or twice weekly continuity clinics. First year fellows see both benign and malignant hematology patients in their continuity clinic. Second year clinic focuses on malignant hematology, prostate, breast, and lung cancer patients and third year fellows have twice a week continuity clinic in which they see patients with both genitourinary and gastrointestinal malignancies. All clinics are staffed by two disease specific faculty members. Patients receiving active treatment by a fellow at the end of the academic year can transition to the fellow’s new clinic to maximize provider continuity.